Naprosyn (Naproxen)

Naproxen blocks both COX‑1 and COX‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, naproxen diminishes inflammation, pain signaling, and fever, providing therapeutic relief in a range of musculoskeletal and inflammatory disorders.

The appropriate dose of Naprosyn is determined by a qualified prescriber based on the specific indication, patient age, weight, and renal or hepatic function. Healthcare professionals tailor the regimen to achieve optimal benefit while minimizing potential risks.

Safety of naproxen during pregnancy and lactation is not fully established. It is generally avoided, especially in the third trimester, because of potential fetal cardiovascular effects and reduced labor progress. Breastfeeding mothers should consult a healthcare provider before use.

To order Naprosyn, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class, but naproxen has a longer half‑life, allowing less frequent dosing, whereas ibuprofen often requires multiple daily doses. Naproxen may carry a slightly higher cardiovascular risk with prolonged use, while ibuprofen is associated with more frequent gastrointestinal irritation in some patients.

Naprosyn should be stored at ambient temperature, preferably below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Naprosyn is taken orally, usually with a full glass of water. It can be taken with or without food, although a meal may reduce stomach upset. Patients should follow the prescriber’s instructions regarding timing and whether the tablet should be swallowed whole or divided.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and severe skin reactions like Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they notice black stools, chest pain, sudden weakness, or widespread rash.

Individuals with a known allergy to naproxen or other NSAIDs, active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal impairment should avoid Naprosyn. It is also contraindicated in the third trimester of pregnancy.